DOI QR코드

DOI QR Code

전하가 다른 PLGA 나노 입자의 생체 안정성 및 암세포에 미치는 영향

The Biostability and Cancer Effect of PLGA Nanoparticles with Different Charges

  • 김인우 (연세대학교 보건과학대학 의공학부) ;
  • 박승빈 (연세대학교 보건과학대학 의공학부) ;
  • 지유현 (연세대학교 보건과학대학 의공학부) ;
  • 박상효 (연세대학교 보건과학대학 의공학부) ;
  • 기재홍 (연세대학교 보건과학대학 의공학부)
  • Kim, Inwoo (Department of Biomedical Engineering, College of Health Sciences, Yonsei University) ;
  • Park, Seungbin (Department of Biomedical Engineering, College of Health Sciences, Yonsei University) ;
  • Ji, Yuhyun (Department of Biomedical Engineering, College of Health Sciences, Yonsei University) ;
  • Park, Sanghyo (Department of Biomedical Engineering, College of Health Sciences, Yonsei University) ;
  • Key, Jaehong (Department of Biomedical Engineering, College of Health Sciences, Yonsei University)
  • 투고 : 2018.01.12
  • 심사 : 2018.05.28
  • 발행 : 2018.06.30

초록

Cancer is a major burden of human disease worldwide. Current chemotherapy has severe side effects because the drugs affect whole body nonspecifically. In addition, the drugs to reach cancer cells are very limited. Over the last two decades, Drug Delivery System (DDS) using nanoparticles has suggested promising results to improve current limitations. In this study, we prepared PLGA nanoparticles with different charge properties and observed their stability and internalization effect to cancer cells. Results using Dynamic Light Scattering (DLS) and Fourier Transform Infrared Spectroscopy (FTIR) confirmed the size and chemical composition of the nanoparticles. The stability of the nanoparticles in pH buffers were variable depending on charge properties. The nanoparticles showed different cytotoxicity and internalization effects to MCF-7 human breast cancer cells. In conclusion, we demonstrated the importance of delicately engineered nanoparticles for better DDS in cancer.

키워드

참고문헌

  1. B. Stewart and C. P. Wild, "World cancer report 2014," Health, 2017.
  2. S. S. Feng and S. Chien, "Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases," Chemical Engineering Science, vol. 58, pp. 4087-4114, 2003. https://doi.org/10.1016/S0009-2509(03)00234-3
  3. K. Cho, X. Wang, S. Nie, Z. G. Chen, and D. M. Shin, "Therapeutic nanoparticles for drug delivery in cancer," Clin Cancer Res, vol. 14, pp. 1310-6, 2008. https://doi.org/10.1158/1078-0432.CCR-07-1441
  4. L. Brannon-Peppas and J. O. Blanchette, "Nanoparticle and targeted systems for cancer therapy," Advanced Drug Delivery Reviews, vol. 64, pp. 206-212, 2012. https://doi.org/10.1016/j.addr.2012.09.033
  5. T. M. Allen and P. R. Cullis, "Drug delivery systems: entering the mainstream," Science, vol. 303, pp. 1818-22, 2004. https://doi.org/10.1126/science.1095833
  6. I. Brigger, C. Dubernet, and P. Couvreur, "Nanoparticles in cancer therapy and diagnosis," Advanced Drug Delivery Reviews, vol. 64, pp. 24-36, 2012. https://doi.org/10.1016/j.addr.2012.09.006
  7. O. C. Farokhzad and R. Langer, "Impact of nanotechnology on drug delivery," ACS Nano, vol. 3, pp. 16-20, 2009. https://doi.org/10.1021/nn900002m
  8. C. Stigliano, J. Key, M. Ramirez, S. Aryal, and P. Decuzzi, "Radiolabeled Polymeric Nanoconstructs Loaded with Docetaxel and Curcumin for Cancer Combinatorial Therapy and Nuclear Imaging," Advanced Functional Materials, vol. 25, pp. 3371-3379, 2015. https://doi.org/10.1002/adfm.201500627
  9. S. Moein Moghimi, "Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology," Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), vol. 6, pp. 553-561, 2006.
  10. T.-R. Lee, M. Choi, A. M. Kopacz, S.-H. Yun, W. K. Liu, and P. Decuzzi, "On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better," Scientific reports, vol. 3, pp. 2079, 2013. https://doi.org/10.1038/srep02079
  11. M. Bivas-Benita, S. Romeijn, H. E. Junginger, and G. Borchard, "PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium," Eur J Pharm Biopharm, vol. 58, pp. 1-6, 2004. https://doi.org/10.1016/j.ejpb.2004.03.008
  12. X. Zhang, M. R. Servos, and J. Liu, "Ultrahigh nanoparticle stability against salt, pH, and solvent with retained surface accessibility via depletion stabilization," J Am Chem Soc, vol. 134, pp. 9910-3, 2012. https://doi.org/10.1021/ja303787e
  13. I. F. Tannock and D. Rotin, "Acid pH in tumors and its potential for therapeutic exploitation," Cancer Res, vol. 49, pp. 4373-84, 1989.
  14. M. J. Masarudin, S. M. Cutts, B. J. Evison, D. R. Phillips, and P. J. Pigram, "Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin," Nanotechnology, science and applications, vol. 8, pp. 67, 2015.
  15. K. Zhang, X. Tang, J. Zhang, W. Lu, X. Lin, Y. Zhang, et al., "PEG-PLGA copolymers: Their structure and structureinfluenced drug delivery applications," Journal of Controlled release, vol. 183, pp. 77-86, 2014. https://doi.org/10.1016/j.jconrel.2014.03.026
  16. O. Boussif, F. Lezoualch, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, et al., "A Versatile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and in-Vivo-Polyethylenimine," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, pp. 7297-7301, 1995. https://doi.org/10.1073/pnas.92.16.7297
  17. D. Cun, C. Foged, M. Yang, S. Frokjaer, and H. M. Nielsen, "Preparation and characterization of poly (DL-lactide-coglycolide) nanoparticles for siRNA delivery," Int J Pharm, vol. 390, pp. 70-5, 2010. https://doi.org/10.1016/j.ijpharm.2009.10.023
  18. S. A. Agnihotri, N. N. Mallikarjuna, and T. M. Aminabhavi, "Recent advances on chitosan-based micro- and nanoparticles in drug delivery," J Control Release, vol. 100, pp. 5-28, 2004. https://doi.org/10.1016/j.jconrel.2004.08.010